Advertisement

Topics

"A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)" Drugs and Medication Database

22:22 EDT 26th March 2019 | BioPortfolio

Here are the most relevant "A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)" Drugs and Medications that we have found in our database.

More Information about "A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)" on BioPortfolio

We have published hundreds of A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) news stories on BioPortfolio along with dozens of A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) Clinical Trials and PubMed Articles about A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) Companies in our database. You can also find out about relevant A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) Drugs and Medications on this site too.

Showing "Study Ocrelizumab Participants With Relapsing Remitting Multiple Sclerosis" Drugs and Medications 1–25 of 25

Probably Relevant

Teriflunomide [amneal pharmaceuticals llc]

These highlights do not include all the information needed to use TERIFLUNOMIDE TABLETS safely and effectively. See full prescribing information for TERIFLUNOMIDE TABLETS.  TERIFLUNOMIDE tablets, for oral use Initial U.S. Approval: 2012

Aubagio [genzyme corp.]

These highlights do not include all the information needed to use AUBAGIO safely and effectively. See full prescribing information for AUBAGIO. AUBAGIO (teriflunomide) tablets, for oral use Initial U.S. Approval: 2012

Ocrevus [genentech, inc.]

These highlights do not include all the information needed to use OCREVUS safely and effectively. See full prescribing information for OCREVUS. OCREVUS (ocrelizumab) injection, for intravenous use Initial U.S. Approval: 2017

Rebif [emd serono, inc.]

These highlights do not include all the information needed to use REBIF safely and effectively. See full prescribing information for REBIF. REBIF (interferon beta-1a), for subcutaneous injectionInitial U.S. Approval: 1996

Possibly Relevant

Tecfidera [biogen inc.]

These highlights do not include all the information needed to use TECFIDERA safely and effectively. See full prescribing information for TECFIDERA.TECFIDERA (dimethyl fumarate) delayed-release capsules, for oral useInitial U.S. Approval: 2013

Mitoxantrone [fresenius kabi usa, llc]

MitoXANTRONE Injection, USP

Avonex [biogen inc.]

These highlights do not include all the information needed to use AVONEX safely and effectively. See full prescribing information for AVONEX.AVONEX (interferon beta-1a) injection, for intramuscular injectionInitial U.S. Approval: 1996

Mitoxantrone [hospira, inc.]

MitoXANTRONE Injection, USP (concentrate)

Plegridy [biogen inc.]

These highlights do not include all the information needed to use PLEGRIDY™ safely and effectively. See full prescribing information for PLEGRIDY.PLEGRIDY (peginterferon beta-1a) injection, for subcutaneous injectionInitial U.S. Approval: 2014

Tysabri [biogen inc.]

These highlights do not include all the information needed to use TYSABRI safely and effectively. See full prescribing information for TYSABRI.TYSABRI (natalizumab) injection, for intravenous useInitial U.S. Approval: 2004

Mitoxantrone [teva parenteral medicines, inc.]

mitoXANTRONE Injection USP (concentrate)

Extavia [novartis pharmaceuticals corporation]

These highlights do not include all the information needed to use EXTAVIA safely and effectively. See full prescribing information for EXTAVIA. EXTAVIA (interferon beta-1b) for injection, for subcutaneous use Initial U.S. Approval: 1993

Betaseron [bayer healthcare pharmaceuticals inc.]

These highlights do not include all the information needed to use BETASERON safely and effectively. See full prescribing information for BETASERON.BETASERON (interferon beta-1b) for injection, for subcutaneous useInitial U.S. Approval: 1993

Teriflunomide [glenmark pharmaceuticals inc., usa]

These highlights do not include all the information needed to use TERIFLUNOMIDE TABLETS safely and effectively. See full prescribing information for TERIFLUNOMIDE TABLETS. TERIFLUNOMIDE tablets, for oral use Initial U.S. Approval: 2012

Lemtrada [genzyme corporation]

These highlights do not include all the information needed to use LEMTRADA safely and effectively. See full prescribing information for LEMTRADA. LEMTRADA (alemtuzumab) injection, for intravenous use Initial U.S. Approval: 2001

Gilenya [novartis pharmaceuticals corporation]

These highlights do not include all the information needed to use GILENYA safely and effectively. See full prescribing information for GILENYA. GILENYA (fingolimod) capsules, for oral use Initial U.S. Approval: 2010

Zinbryta [abbvie]

These highlights do not include all the information needed to use ZINBRYTA safely and effectively. See full prescribing information for ZINBRYTA.ZINBRYTA (daclizumab) injection, for subcutaneous useInitial U.S. Approval: 2016

Baclofen [a-s medication solutions]

Baclofen Tablets, USP

Baclofen [bryant ranch prepack]

BACLOFEN TABLETS, USP

Baclofen [par pharmaceutical]

Baclofen Tablets, USP

Baclofen [blenheim pharmacal, inc.]

BACLOFEN TABLETS, USP

Baclofen [stat rx usa llc]

NA

Baclofen [preferred pharmaceuticals, inc]

Baclofen Tablets USP Revised: January 2004 Rx only

Baclofen [aidarex pharmaceuticals llc]

BACLOFEN TABLETS, USP

Baclofen [bryant ranch prepack]

BACLOFEN TABLETS, USP



Advertisement
Quick Search
Advertisement
Advertisement